Shropshire, UK - Polymer consultancy Smithers Rapra has added speakers to the line up for its fourth international conference on REACH, 20-22 Jan 2009, in Houston, Texas.
Joerg Lebsanft, head of Unit for Evaluation, at the European Chemicals Agency (ECHA) in Helsinki will open the conference with an update on the implementation activities at ECHA and will go on to talk about effective testing programmes under REACH.
ECHA's involvement in this important meeting will not only give delegates an opportunity to hear direct from the agency about plans for the year ahead, said Smithers. but also to provide feedback to agency representatives on how REACH is working at a grass roots level across the US.
Smithers Rapra- - a subsidiary of US-based independent testing, research and consulting organisation, the Smithers Group -- also has as a speaker Dr Brian Magee, vice president and principal toxicologist, AMEC Earth & Environmental. Amec provides consultancy, engineering and project management services to the world's energy, power and process industries. Speaking on 'Supply Chain Communication,' Dr Magee will offer help for global companies that manufacture articles, such as appliances, which have no intended substance releases. The talk will discuss their REACH requirements and offer the strategies and experiences of such a global article manufacturer.
Also speaking is Emma Chynoweth, contributing editor at Chemical Watch, an online publisher of chemicals legislation, whose paper "REACH: Past, present and issues for 2009 and beyond," will address REACH and other chemical safety regulations in the pipeline, both in the EU and US. Specifically, Chynoweth will look at how REACH will influence CHAMP (NAFTA's chemicals assessment and management programme) and the likely reform of TSCA (the US Toxic Substances Control Act) as well as other pressures on chemical safety, for example, from the supply chain and non-government organisations.
Timed to coincide with the end of pre-registration for REACH, and ECHA's publication of a list of pre-registered substances, this conference aims to provide practical solutions to the ever evolving technical and legal challenges that REACH poses.